THE ROLE OF IMMUNE FACTORS IN THE DEVELOPMENT OF TRIGEMINAL NERVE NEURALGIA
Keywords:
trigeminal neuralgia, pain syndrome, interleukin -6 (IL6)Abstract
We visited Bukhara region, Jondor District Medical Association, Central Polyclinic, where 92 patients with trigeminal neuralgia aged 17 to 70 years and 30 patients in the control group were prescribed interleukin -6 (IL-6) in blood serum. 53 of the patients involved in the study were 1 group of patients with very strong pain intensity and 39 patients with moderate intensity pain.
References
Карлов В.А, Неврология лица. – М., 1991. – 288 С
Оберманн М. Последние достижения в понимании/лечении невралгии тройничного нерва. F1000Research. 2019;8:505. doi: 10.12688/f1000research.16092.1. [ DOI ] [ Бесплатная статья PMC ] [ PubMed ] [ Google Scholar ] Перейти обратно:1 2 3 Неврология. Национальное руководство. — ГЭОТАР-Медиа, 2010. — 2116 с. — 2000 экз. — ISBN 978-5-9704-0665-6.
Jumpupto:a b c OkesonJP (2005). "6". In Lindsay Harmon (ed.). Bell's orofacial pains: the clinical management of orofacial pain. Quintessence Publishing Co, Inc. p. 115. ISBN 0-86715-439-X. Archived from the original on 2014-01-12.
Jiang X., Zhou R., Zhang Y.“Interleykin-17 as a potential therapeutic target for chronic pain”. Immunologi 29. Siptember 2022.
Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis [published correction appears in Brain. 2002; 125 (pt 3)
:687] Brain. 2001;124 (pt 12) :2347-2360.
